Unknown

Dataset Information

0

Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.


ABSTRACT: AV411 (ibudilast; 3-isobutyryl-2-isopropylpyrazolo-[1,5-a]pyridine) is an antiinflammatory drug that was initially developed for the treatment of bronchial asthma but which also has been used for cerebrovascular and ocular indications. It is a nonselective inhibitor of various phosphodiesterases (PDEs) and has varied antiinflammatory activity. More recently, AV411 has been studied as a possible therapeutic for the treatment of neuropathic pain and opioid withdrawal through its actions on glial cells. As described herein, the PDE inhibitor AV411 and its PDE-inhibition-compromised analog AV1013 inhibit the catalytic and chemotactic functions of the proinflammatory protein, macrophage migration inhibitory factor (MIF). Enzymatic analysis indicates that these compounds are noncompetitive inhibitors of the p-hydroxyphenylpyruvate (HPP) tautomerase activity of MIF and an allosteric binding site of AV411 and AV1013 is detected by NMR. The allosteric inhibition mechanism is further elucidated by X-ray crystallography based on the MIF/AV1013 binary and MIF/AV1013/HPP ternary complexes. In addition, our antibody experiments directed against MIF receptors indicate that CXCR2 is the major receptor for MIF-mediated chemotaxis of peripheral blood mononuclear cells.

SUBMITTER: Cho Y 

PROVIDER: S-EPMC2895110 | biostudies-literature | 2010 Jun

REPOSITORIES: biostudies-literature

altmetric image

Publications

Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast.

Cho Yoonsang Y   Crichlow Gregg V GV   Vermeire Jon J JJ   Leng Lin L   Du Xin X   Hodsdon Michael E ME   Bucala Richard R   Cappello Michael M   Gross Matt M   Gaeta Federico F   Johnson Kirk K   Lolis Elias J EJ  

Proceedings of the National Academy of Sciences of the United States of America 20100608 25


AV411 (ibudilast; 3-isobutyryl-2-isopropylpyrazolo-[1,5-a]pyridine) is an antiinflammatory drug that was initially developed for the treatment of bronchial asthma but which also has been used for cerebrovascular and ocular indications. It is a nonselective inhibitor of various phosphodiesterases (PDEs) and has varied antiinflammatory activity. More recently, AV411 has been studied as a possible therapeutic for the treatment of neuropathic pain and opioid withdrawal through its actions on glial c  ...[more]

Similar Datasets

| S-EPMC6393433 | biostudies-literature
| S-EPMC7549106 | biostudies-literature
| S-EPMC3436310 | biostudies-literature
| S-EPMC3397911 | biostudies-literature
| S-EPMC170922 | biostudies-literature
| S-EPMC6311451 | biostudies-literature
| S-EPMC2845658 | biostudies-literature
2022-04-08 | PXD031143 | Pride
| S-EPMC8553141 | biostudies-literature
| S-EPMC10350922 | biostudies-literature